Sleepmaxxing: what the better-sleep trend can actually offer

What happens when regular bedtimes, supplements, and sleep scores become one elaborate program? That is the idea behind “sleepmaxxing,” a trend that bundles together very different approaches to sleep. Some have a reasonable scientific foundation. Others remain uncertain, and some can make sleep more stressful. Whether the trend helps depends on its individual parts. Studies of those parts do not establish that the whole package works.

A comfortable bedroom and a consistent schedule deserve a different assessment from apigenin, mouth tape, or the pursuit of a higher tracker score every night. The useful distinction is between a habit that may support sleep and a treatment for an existing sleep disorder. Good habits can be worthwhile without turning bedtime into a performance test.

What is sleepmaxxing?

Sleepmaxxing brings the internet’s self-optimization culture to sleep. People following the trend usually combine basic sleep hygiene with supplements, bedroom changes, and consumer sleep trackers. They keep adjusting their habits and surroundings in the hope of getting the best possible rest.

The term circulates on platforms such as TikTok and Reddit. There is no single standardized protocol or securely established origin date. Its practices mix ideas from behavioral sleep medicine with supplement marketing. Sleep duration and quality are associated with health, but that does not show that the combinations promoted online work. Sleepmaxxing is sometimes grouped with “Monk Mode” or “75 Hard,” although it focuses more narrowly on sleep. Some enthusiasts pursue changes in sleep architecture, the pattern and distribution of sleep stages, as well as more restful nights. Relevant research covers sleep duration and cardiovascular health and behavioral treatment for insomnia.

People drawn to sleepmaxxing often have four goals:

• Sleep longer and better by combining several changes.
• Fall asleep faster with supplements such as magnesium glycinate, apigenin, or tart cherry.
• Improve sleep through a cool room, often around 67 °F or 19.4 °C, blackout curtains, and deliberate control of light exposure.
• Measure improvements objectively using a consumer sleep tracker.

These are aims, not four established benefits of the trend. The quality of the evidence differs considerably between them.

What the research shows

Sleepmaxxing does not have one overall evidence rating. Different practices have been studied in different populations, using different outcomes. A result for one ingredient cannot be transferred to a supplement combination or an entire evening routine. The distinctions below describe the available evidence and its limitations rather than assign formal evidence grades to the trend.

Basic sleep hygiene: useful foundations, but limited as insomnia treatment

Sleep hygiene includes regular schedules and a bedroom environment that makes sleep easier. A 2025 meta-analysis examined 42 randomized trials involving 4,245 adults. Insomnia scores improved from before to after sleep-hygiene education, but this was not equivalent to showing superiority over a control group. Sleep-hygiene education performed worse than structured cognitive behavioral therapy for insomnia, or CBT-I, and several other active treatments. Most trials had a high risk of bias. The review therefore does not establish that sleep hygiene alone is an adequate treatment for insomnia.

Regularity is still a reasonable part of sleep care. In the MESA cohort, irregular sleep schedules were associated with cardiovascular events even after accounting for total sleep duration. That observational association does not prove that making bedtimes regular prevents those events, but it helps explain why consistency receives attention.

Light also has a biological basis: evening light can delay the body clock and suppress melatonin secretion. A review of light exposure and circadian rhythms describes these effects. For established insomnia, however, sleep hygiene alone often falls short. It has repeatedly performed less well than CBT-I, a structured treatment rather than a longer checklist of bedtime rules. See the review of sleep-hygiene education and the analysis of CBT-I components and delivery formats.

Magnesium glycinate, apigenin, and tart cherry: different products, different evidence

Magnesium has some supportive human sleep research, although the evidence remains limited. A meta-analysis in older adults found that oral magnesium might shorten the time needed to fall asleep. Its evidence was low to very low certainty, and it examined oral magnesium generally. It cannot establish that magnesium glycinate is the best form for sleep.

A 2025 randomized trial tested magnesium bisglycinate in otherwise healthy adults reporting poor sleep. After four weeks, Insomnia Severity Index scores fell by 3.9 points with magnesium and 2.3 points with placebo. The difference was small. The study used 250 mg of elemental magnesium daily, but that is a description of the trial, not a personal dosing recommendation. It measured self-reported insomnia symptoms, not proof of a large improvement in objectively measured sleep stages.

Tart cherry results are mixed. In a small randomized crossover trial, 20 volunteers consumed tart cherry concentrate or placebo for seven days. The cherry condition increased melatonin measures and improved some sleep outcomes. A separate study in healthy adults found no sleep benefit from Montmorency tart cherry supplementation. Different participants, products, and study designs matter when interpreting those findings.

Apigenin has much less direct human sleep evidence. A proposed mechanism involves effects at GABA-A receptors, discussed in a review of apigenin. Some prescription anxiety and sleep medications also act through these receptors. Sharing a possible biological target does not establish comparable effects, an effective supplement dose, or a sleep benefit in people. Well-controlled human sleep trials are still needed.

The practical point is not that all three supplements are interchangeable or that none could help. It is that the evidence for each should be judged separately. A plausible mechanism, a small positive trial, and a replicated clinical benefit are different levels of information.

Is 67 °F optimal for everyone? No single temperature has been established

A comfortably cool environment may support sleep, but cooler is not automatically better in every setting. In a study of people with obstructive sleep apnea, room temperature affected both sleep and breathing outcomes. Results from people with a breathing disorder cannot define the ideal bedroom temperature for everyone.

A 2025 randomized crossover study compared radiant and convection cooling in just seven healthy women, with room air temperature set at 26 °C, or 78.8 °F. Radiant cooling improved some subjective and EEG-based outcomes relative to convection cooling. Humidity and airflow also differed. This was a small comparison of cooling methods, not a trial demonstrating that 67 °F is optimal or that all active cooling products improve sleep.

The thermoneutral zone is the range in which the body can maintain its temperature without additional effort. Bedding, clothing, age, body composition, and adaptation to the environment all affect thermal comfort. The commonly cited 67 °F, about 19.4 °C, may be a reasonable starting point for some people, but it is not a scientifically established universal target. Feeling comfortably cool is more useful than enduring an uncomfortable temperature to meet an online rule.

Mouth taping: limited studies and meaningful safety concerns

The evidence does not support recommending mouth taping to the general population for better sleep or breathing. A 2025 systematic review found ten small studies of mouth closure methods. Some reported improvements in selected patients, while others did not. Many excluded people with nasal obstruction, limiting how widely the results can be applied. The review also identified potential serious harms when the practice is used indiscriminately, particularly when nasal breathing is obstructed.

This is more than a question of whether an online trick improves a sleep score. Snoring, witnessed pauses in breathing, and daytime sleepiness warrant evaluation before trying devices that alter breathing. A validated questionnaire such as STOP-Bang can help assess the likelihood of obstructive sleep apnea, or OSA. It does not diagnose the condition on its own or establish that taping the mouth is safe. The STOP-Bang paper supports screening, not mouth taping.

Relentless tracker optimization: limited evidence of benefit, possible downsides

Paying attention to sleep data can itself become stressful. “Orthosomnia” describes a preoccupation with achieving ideal sleep, often driven by tracker data. A 2024 cross-sectional study estimated its frequency using a proposed research algorithm. That supports further study of the phenomenon; it does not establish a universally accepted diagnosis or show that trackers caused every participant’s sleep problems.

The worry can center on uncertain measurements. A multicenter validation study of 11 consumer sleep trackers found meaningful differences from polysomnography, a detailed clinical sleep assessment. A living umbrella review of consumer wearables also found limitations in sleep measurement. A watch’s estimate of deep sleep is not the same thing as a clinical recording of sleep stages.

Trackers can offer clues and trends. They do not treat sleep disorders. If an apparently bad score triggers more worry and more adjustments, tracking may be working against the rest you hoped to get. How you feel and function during the day still matters.

Trying changes without making sleep harder

A manageable approach makes it easier to judge individual changes. It also reduces the temptation to stack supplements or spend more time analyzing sleep than sleeping. The five steps below offer a framework for observation, not a tested sleepmaxxing treatment protocol. Their time windows are practical examples, not universal medical instructions.

1. Start with a simple sleep diary for seven days, without a tracker if that helps. Record how you experience sleep before making changes. Some sleepmaxxing plans add baseline blood tests for morning cortisol, ferritin, vitamin D, free T4, TSH, and HbA1c. These tests do not form a validated sleep-success panel. Order them only when symptoms and a clinical question justify them; the biomarker section below explains the distinctions.

2. Focus on the basics: reasonably consistent bedtimes and wake times, a comfortable room, darkness when sleeping, and a deliberate approach to light. Aiming for times within about 30 minutes of your usual schedule can be a practical experiment, but it is not a pass-or-fail rule. Similarly, the often-suggested 60–68 °F, about 15.6–20 °C, is a starting range rather than a requirement. Avoid treating alcohol as a sleep aid. Leaving three hours between a drink and bedtime is sometimes proposed, but it does not guarantee that alcohol will have no effect on sleep.

3. If a supplement is appropriate after considering your health and medications, introduce only one new product at a time. Magnesium glycinate, apigenin, and tart cherry have different evidence, so they should not be treated as a proven package. Observing one change for two to four weeks may help you notice patterns, but that interval is not validated for every product. The “Sleepy Girl Mocktail” combines tart cherry with magnesium and a prebiotic soda; evidence for tart cherry alone does not establish the value or safety of the combined drink.

4. Keep monitoring simple. Checkboxes and a brief note about sleep and daytime functioning may be enough. If you use a wearable, treat its readings as trends rather than a diagnosis or instructions to maximize particular sleep stages. Notice whether looking at the data reassures you or makes you more anxious.

5. Reassess rather than adding more interventions indefinitely. A twelve-week review can be a convenient checkpoint, not a reason to delay help for worsening symptoms. Repeating the same blood tests under similar morning conditions and at the same laboratory still requires a medical reason; consistency does not validate an unnecessary test panel. Stop a new measure and seek advice if it worsens sleep or causes new physical or psychological symptoms, including gastrointestinal or pelvic discomfort. Snoring, breathing pauses, or daytime sleepiness call for assessment rather than another supplement. Mouth taping is not a recommended first step in this framework.

Where sleepmaxxing can go wrong

Concern about a score can produce a cycle of measuring, tension, and worse sleep. Taking a break from a tracker for two to four weeks is one possible way to reduce the pressure. If sleep feels better, that may suggest tracking was contributing to distress. It is not a diagnostic test or proof that the device was the sole cause.

A stack of supplements also cannot reliably compensate for an irregular schedule, bright light at night, or evening alcohol. Sleep timing and the bedroom environment remain sensible first places to look. The studies cited here do not provide a reliable numerical comparison between the benefits of supplements and those of regular schedules or better light habits. It would be misleading to claim that every supplement combination has been directly tested against those foundations.

Mouth taping adds a different concern: breathing problems may be missed while someone tries to stop mouth breathing at home. The direct review described above gives reasons for caution, especially with nasal obstruction. Snoring, witnessed breathing pauses, and daytime sleepiness should lead to clinical assessment, possibly including a sleep study. STOP-Bang screening can inform that assessment, but it is not a safety clearance for mouth tape.

Sleepmaxxing is also a problem when it postpones appropriate care. Persistent insomnia, mental health symptoms, hormonally related sleep disruption, and problems involving alcohol or other substances are not reliably treated by a supplement bundle. CBT-I is among the best-supported behavioral treatments for chronic insomnia, as described in the AASM review. A network meta-analysis of CBT-I explores its components and formats; it does not compare CBT-I directly with every possible supplement combination.

Who might benefit, and when to get clinical advice

The most useful version of sleepmaxxing may be the least elaborate: an otherwise healthy adult uses the trend as a reason to give sleep more room in daily life. Keeping workable habits for 60–90 days may help establish a routine, but that period is not a proven treatment course. After irregular schedules, shift work, or travel, planning for sleep can be worthwhile, although circadian problems sometimes need more tailored advice than a standard bedtime checklist.

Before starting an optimization program, clinical advice is particularly useful in these situations:

• Pregnancy or plans to become pregnant: check which measures, especially supplements, are appropriate.
• Current treatment for a mental health condition or a history of an eating disorder: rigid tracking can become another source of pressure or control.
• Suspected obstructive sleep apnea: snoring together with daytime sleepiness deserves assessment. OSA frequently goes unrecognized worldwide, as discussed in the global burden review. Mouth taping does not resolve the diagnostic question.
• An established insomnia disorder: CBT-I is a first-line treatment. A supplement package is not a substitute.

These circumstances do not rule out ordinary, individually appropriate sleep habits. The concern is the particular intervention: a supplement, a device that changes breathing, or tracking that increases distress. A reasonable schedule need not become a rigid restriction.

Which biomarkers might be worth checking?

There is no validated blood-test protocol that can establish whether sleepmaxxing is working. The usefulness of a laboratory test depends on symptoms and the medical question. Your experience of sleep and daytime functioning remain relevant outcomes in their own right.

Some programs propose comparing results on day 0 and day 90. The intention is to put objective measurements alongside subjective improvement. But the tests below address different questions; combining them does not create one general test of successful sleep. A measurable number is not automatically the most meaningful measure of what you are trying to improve.

• Morning cortisol: This hormone is connected to the hypothalamic-pituitary-adrenal, or HPA, axis. A high morning result does not by itself establish chronic sleep deprivation, and the cited material does not validate an expected fall after 60–90 days of sleepmaxxing. It should not be used as a routine score of how well a sleep program is working.

• Ferritin and iron status: Iron status can matter in restless legs syndrome, which can disrupt sleep. A threshold below 50 ng/mL sometimes appears in online plans, but it is not a universal adult sleep target. The 2025 AASM guideline uses adult RLS-specific consensus thresholds, including ferritin at or below 75 ng/mL or transferrin saturation below 20%, to guide clinician-directed iron treatment. These thresholds are not an instruction for everyone with poor sleep to take iron, and the guideline notes that the consensus thresholds themselves have not been empirically tested.

• Vitamin D: Low 25-hydroxyvitamin D has been associated with poorer sleep in observational research. Treating a confirmed deficiency may be appropriate for broader health reasons. The association alone does not establish that correcting it will improve everyone’s sleep, or that vitamin D testing should precede every sleep intervention.

• Free T4 and TSH: These help assess thyroid function. Whether an unrecognized thyroid disorder should be investigated depends on the symptoms and clinical context. Sleep optimization by itself does not justify a thyroid panel for everyone.

• HbA1c: This reflects longer-term blood glucose exposure and can be useful for appropriate diabetes assessment. It does not, by itself, explain nighttime waking or night sweats. Using it as a routine baseline simply because poor sleep is the main complaint goes beyond what the cited evidence establishes.

• The apnea-hypopnea index, or AHI: This is a sleep-study measure rather than a blood biomarker. When snoring, witnessed breathing pauses, or daytime sleepiness raise concern about sleep apnea, a suitable sleep assessment is more relevant than a general blood panel. Blood tests do not replace that evaluation.

Lab values fluctuate. A change in the hoped-for direction does not prove that a combination of sleep interventions caused it. Unchanged values do not rule out better sleep. Neither result, by itself, determines whether someone needs CBT-I, thyroid testing, a sleep-apnea evaluation, or a different supplement. Those decisions should follow symptoms and clinical assessment, not an unvalidated dashboard.

When sleepmaxxing is not the right tool

Chronic insomnia, persistent exhaustion, suspected sleep apnea, depressive symptoms, hormonally related sleep disruption, and substance-related problems warrant appropriate assessment. CBT-I is a first-line treatment for chronic insomnia; the systematic review describes its evidence. Suspected OSA may require formal sleep testing and specialist input.

For readers in the United States, the 988 Suicide & Crisis Lifeline is available by calling or texting 988. SAMHSA’s National Helpline, 1-800-662-4357, provides treatment referrals and information for mental health and substance-use concerns. Both operate 24/7. These are US services, not German helpline numbers, and SAMHSA’s referral service has a different role from crisis counseling.

Frequently asked questions

What is sleepmaxxing?

Sleepmaxxing applies internet self-optimization culture to sleep. It usually combines consistent bedtimes, a cool room, and attention to light with supplements such as magnesium glycinate, apigenin, and tart cherry. Mouth tape, sleep trackers, and weighted blankets may also be included.

Some foundations have scientific support, although ordinary sleep hygiene is not the same as insomnia treatment. Other components, especially indiscriminate mouth taping and compulsive tracking, have little basis as general sleep-improvement strategies and can create problems of their own.

Where did sleepmaxxing come from?

The term circulates on TikTok, Reddit, and other social platforms. Its exact origin is not well established, and it describes a collection of practices rather than one defined program. Some ideas overlap with behavioral sleep medicine, while others come from supplement marketing. The AASM review evaluates behavioral and psychological insomnia treatments; it is not a study of the social-media trend’s origins.

Does sleepmaxxing actually work?

It depends on the individual change. A comfortable sleep environment and workable, consistent timing can be useful foundations. The 2025 sleep-hygiene meta-analysis found improvement over time but weaker results than CBT-I and substantial study limitations, so it does not validate sleepmaxxing as a package.

Oral magnesium has limited supportive evidence. The cited meta-analysis cannot be applied indiscriminately to magnesium glycinate or every age group. Apigenin has little direct human sleep evidence, and tart cherry findings are mixed.

The cited material does not establish general benefits from mouth taping, weighted blankets in adults without a relevant clinical condition, or compulsive tracking. For chronic insomnia, structured CBT-I has a stronger treatment basis than sleep hygiene alone.

How long does it take to notice results?

There is no established timeline for sleepmaxxing as a whole. Comparing biomarkers on day 0 and day 90 is not a validated standard, and someone may notice subjective changes sooner.

Symptoms and perceived improvements remain relevant. A blood-test panel is not a proven replacement for them or an inherently more reliable way to judge progress. The biomarker section explains why a change in a number and a meaningful change in sleep are not necessarily the same thing.

Who should avoid sleepmaxxing?

People with suspected sleep apnea, such as snoring together with daytime sleepiness, should seek assessment rather than treat the problem with an online protocol. Advice is also useful with an active eating disorder, a distressing history of one, or substantial mental health symptoms alongside insomnia.

The concern is especially rigid tracking used as a form of control. It does not mean that basic, comfortable sleep habits must be abandoned. The right response depends on the individual practice and the person’s health.

What are the risks?

A preoccupation with sleep scores can produce anxiety and make sleep harder. This is the pattern described as orthosomnia. Consumer trackers also differ from clinical polysomnography, so inaccurate estimates can fuel unnecessary worry. See the original orthosomnia report and tracker validation study.

Mouth taping has limited supporting evidence and potential breathing-related harms, especially with nasal obstruction. A STOP-Bang assessment can help identify OSA risk but cannot certify that taping is safe.

Adding more supplements can also distract from conditions that deserve assessment, including sleep apnea, thyroid dysfunction, iron deficiency, or a genuine vitamin D deficiency. Not every poor sleeper has one of these conditions, and not every condition calls for the same tests.

Is orthosomnia real?

Distress and preoccupation associated with sleep tracking have been described in clinical reports and research. The central concern is that trying too hard to perfect sleep through monitoring may make it worse. The 2024 prevalence study used a proposed algorithm, so it should not be treated as a universally agreed diagnostic test or proof that all tracker users are at risk.

Which biomarkers should be monitored?

No generally recommended sleepmaxxing panel follows from the cited research. Proposed day-0 and day-90 panels include morning cortisol, ferritin, vitamin D, free T4 and TSH, and HbA1c. These are sometimes presented as five groups of markers, not one validated five-marker test.

The idea is to compare laboratory changes with subjective improvement. Associations between sleep and individual markers are not enough to establish that this combination is useful. A clinician can help decide whether particular tests answer a real question and how to interpret them. With snoring or daytime sleepiness, evaluation for a sleep disorder, including AHI when appropriate, should take priority over simply adding another supplement.

Sources

• Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, Sateia MJ, Troxel WM, Zhou ES, Kazmi U, Heald JL, Martin JL (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 17(2), 263-298. https://doi.org/10.5664/jcsm.8988

• Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA (2011). Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. European heart journal, 32(12), 1484-92. https://doi.org/10.1093/eurheartj/ehr007

• Ruan JY, Liu Q, Chung KF, Ho KY, Yeung WF (2025). Effects of sleep hygiene education for insomnia: A systematic review and meta-analysis. Sleep medicine reviews, 82, 102109. https://doi.org/10.1016/j.smrv.2025.102109

• Huang T, Mariani S, Redline S (2020). Sleep Irregularity and Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. Journal of the American College of Cardiology, 75(9), 991-999. https://doi.org/10.1016/j.jacc.2019.12.054

• Tähkämö L, Partonen T, Pesonen AK (2019). Systematic review of light exposure impact on human circadian rhythm. Chronobiology international, 36(2), 151-170. https://doi.org/10.1080/07420528.2018.1527773

• Chung KF, Lee CT, Yeung WF, Chan MS, Chung EW, Lin WL (2018). Sleep hygiene education as a treatment of insomnia: a systematic review and meta-analysis. Family practice, 35(4), 365-375. https://doi.org/10.1093/fampra/cmx122

• Furukawa Y, Sakata M, Yamamoto R, Nakajima S, Kikuchi S, Inoue M, Ito M, Noma H, Takashina HN, Funada S, Ostinelli EG, Furukawa TA, Efthimiou O, Perlis M (2024). Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults: A Systematic Review and Component Network Meta-Analysis. JAMA psychiatry, 81(4), 357-365. https://doi.org/10.1001/jamapsychiatry.2023.5060

• Mah J, Pitre T (2021). Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC complementary medicine and therapies, 21(1), 125. https://doi.org/10.1186/s12906-021-03297-z

• Schuster J, Cycelskij I, Lopresti A, Hahn A (2025). Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nature and science of sleep, 17, 2027-2040. https://doi.org/10.2147/NSS.S524348

• Howatson G, Bell PG, Tallent J, Middleton B, McHugh MP, Ellis J (2012). Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. European journal of nutrition, 51(8), 909-16. https://doi.org/10.1007/s00394-011-0263-7

• Hillman AR, Trickett O, Brodsky C, Chrismas B (2026). Montmorency tart cherry supplementation does not impact sleep, body composition, cellular health, or blood pressure in healthy adults. Nutrition and health, 32(1), 239-248. https://doi.org/10.1177/02601060221111230

• Kashyap P, Shikha D, Thakur M, Aneja A (2022). Functionality of apigenin as a potent antioxidant with emphasis on bioavailability, metabolism, action mechanism and in vitro and in vivo studies: A review. Journal of food biochemistry, 46(4), e13950. https://doi.org/10.1111/jfbc.13950

• Valham F, Sahlin C, Stenlund H, Franklin KA (2012). Ambient temperature and obstructive sleep apnea: effects on sleep, sleep apnea, and morning alertness. Sleep, 35(4), 513-7. https://doi.org/10.5665/sleep.1736

• Park I, Cui Y, Kawana F, Tominaga M, Miyamura R, Yamagishi H, Okado M, Miyamura M, Nakamura S, Tanigawa C, Kokubo T, Yanagisawa M, Tokuyama K (2025). Subjective and objective quality of sleep with radiant or convection cooling systems: a randomized, cross-over trial. Scientific reports, 15(1), 35119. https://doi.org/10.1038/s41598-025-19163-8

• Chung F, Abdullah HR, Liao P (2016). STOP-Bang Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea. Chest, 149(3), 631-8. https://doi.org/10.1378/chest.15-0903

• Jahrami H, Trabelsi K, Husain W, Ammar A, BaHammam AS, Pandi-Perumal SR, Saif Z, Vitiello MV (2024). Prevalence of Orthosomnia in a General Population Sample: A Cross-Sectional Study. Brain sciences, 14(11). https://doi.org/10.3390/brainsci14111123

• Lee T, Cho Y, Cha KS, Jung J, Cho J, Kim H, Kim D, Hong J, Lee D, Keum M, Kushida CA, Yoon IY, Kim JW (2023). Accuracy of 11 Wearable, Nearable, and Airable Consumer Sleep Trackers: Prospective Multicenter Validation Study. JMIR mHealth and uHealth, 11, e50983. https://doi.org/10.2196/50983

• Doherty C, Baldwin M, Keogh A, Caulfield B, Argent R (2024). Keeping Pace with Wearables: A Living Umbrella Review of Systematic Reviews Evaluating the Accuracy of Consumer Wearable Technologies in Health Measurement. Sports medicine (Auckland, N.Z.), 54(11), 2907-2926. https://doi.org/10.1007/s40279-024-02077-2

• Iannella G, Pace A, Bellizzi MG, Magliulo G, Greco A, De Virgilio A, Croce E, Gioacchini FM, Re M, Costantino A, Casale M, Moffa A, Lechien JR, Cocuzza S, Vicini C, Caranti A, Marchese Aragona R, Lentini M, Maniaci A (2025). The Global Burden of Obstructive Sleep Apnea. Diagnostics (Basel, Switzerland), 15(9). https://doi.org/10.3390/diagnostics15091088

• Baron KG, Abbott S, Jao N, Manalo N, Mullen R (2017). Orthosomnia: Are Some Patients Taking the Quantified Self Too Far?. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 13(2), 351-354. https://doi.org/10.5664/jcsm.6472

• Rhee J, Iansavitchene A, Mannala S, Graham ME, Rotenberg B (2025). Breaking social media fads and uncovering the safety and efficacy of mouth taping in patients with mouth breathing, sleep disordered breathing, or obstructive sleep apnea: A systematic review. PLOS One, 20(5), e0323643. https://doi.org/10.1371/journal.pone.0323643 PubMed

• Winkelman JW et al. (2025). Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 21(1),137–152. https://doi.org/10.5664/jcsm.11390 PubMed

• 988 Lifeline. Get Help. https://988lifeline.org/get-help/

• SAMHSA. National Helpline. https://www.samhsa.gov/find-help/helplines/national-helpline